Piramal Pharma Ltd

NSE: PPLPHARMA · BSE: 543635 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹206.59
Market cap: ₹27,504 Cr
Revenue (annual): ₹8,869 Cr
Net profit (annual): ₹-325.9 Cr
P/E (TTM): -87.7×Sector 49.7×
Promoter holding: 34.80%-0.06% QoQ
FII holding: 12.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 7 Other Announcement 6 Financial Results 3 Share Pledge 2 Results Update 2 Regulatory Approval 2 Merger & Restructuring 2 Employee Stock Options 2 Annual General Meeting 2 Management Change 1 Earnings Call 1 Board Meeting Date 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 Jul 2026 20:49 IST NSE

Results Update

Piramal Pharma Results Update

Piramal Pharma Limited reported a consolidated revenue of ₹2,270 Crore for Q1 FY27, marking a 17% YoY increase. EBITDA for the quarter rose by 72% to ₹285 Crore.

Value: ₹2,270 Cr

Read the filing ↗

28 Apr 2026 21:17 IST NSE

Results Update

Piramal Pharma Results Update

Piramal Pharma Limited announced its FY26 results, reporting revenue of ₹8,869 Crore. Performance was impacted by inventory destocking and slower inflows, although the company maintained a strong quality track record with zero OAI. Management remains optimistic for FY27 growth driven by the CDMO and CHG businesses.

Value: ₹8,869 Cr

Read the filing ↗